CAS: 16188-61-7; 4-Benzyl-2-(2-(Dimethylamino)Ethyl)Phthalazin-1(2H)-One
该化合物是一种属于抗脊髓灰质炎类的化学化合物,主要用于抗脊髓灰质炎特性,通过阻拦对引起过敏症状的体内一种物质 ----直肠胺 ----作用帮助减轻过敏反应,这是体内一种物质,引起过敏症状;Talastine的特征是能够跨越血液脑屏障,可能导致...
- 英文名称4-Benzyl-2-(2-(Dimethylamino)Ethyl)Phthalazin-1(2H)-One
- 中文名称他拉斯汀
- IUPAC名称4-benzyl-2-(2-(dimethylamino)ethyl)phthalazin-1(2H)-one
- 其它别名Talastine; 4-Benzyl-2-[2-(Dimethylamino)Ethyl]Phthalazin-1(2H)-One; 4-Benzyl-2-[2-(Dimethylamino)Ethyl]Phthalazin-1-One; 1(2H)-Phthalazinone, 2-[2-(Dimethylamino)Ethyl]-4-(Phenylmethyl)-
- CAS编号16188-61-7
- FDA UNII编号:49AB2PA48B
- 分子式:C19H21N3O分子量:307.4
- 产品CID: 817568
- 产品分类有机原料 → 有机杂环化合物 → 二氮杂萘
物理性质
MSDS等安全信息
上下游产品
CAS号107-99-3 2-氯-N,N-二甲基乙胺合成工艺路线路线简述
📜2-氯-N,N-二甲基乙胺,Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于xylene体系中,化学反应生成他拉斯汀
参考文献:De1046625
标题:De1046625
海关参考信息
- 2902300000-甲苯
2921199090-其他无环单胺 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2007148246-A1
优先权日:2005-08-11
标题:Nucleic Acid-Based Matrixes
发明人：LUO DAN; LI YOUGEN
权利人:LUO DAN; LI YOUGEN
摘要:Various nucleic acid-based matrixes are provided, comprising nucleic acid monomers as building blocks, as well as nucleic acids encoding proteins, so as to produce novel biomaterials. Methods of utilizing such biomaterials include delivery of biologically active agents, cell and tissue culture, and cell-free protein synthesis.
专利号:US-8486621-B2
优先权日:2005-08-11
标题 :Nucleic acid-based matrixes
发明人：LUO DAN; UM SOONG HO
权利人:LUO DAN; UM SOONG HO; CORNELL RES FOUNDATION INC
摘要:Various nucleic acid-based matrixes are provided, comprising nucleic acid monomers as building blocks, as well as nucleic acids encoding proteins, so as to produce novel biomaterials. Methods of utilizing such biomaterials include cell-free protein synthesis.
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
参考文献:10.1023/a:1011115824070
摘要:Duart MJ, García-Domenech R, Antón-Fos GM, Gálvez J. Optimization of a mathematical topological pattern for the prediction of antihistaminic activity. Journal of Computer-Aided Molecular Design. 2001 Jun;15(6):561–72. doi: 10.1023/a:1011115824070.
参考文献:10.1007/bf00531142
📝 需求与反馈
尽可能描述清楚需求与问题信息
